Table 1.
Clinicopathological characteristics of patients with breast cancer and healthy control
| Clinical characteristic | Breast cancer (n = 58) | Healthy control (n = 93) |
|---|---|---|
| Age, years | ||
| Median | 47 | 48 |
| Range | 21-78 | 27-74 |
| Menstrual status | ||
| Premenopausal | 24 (41.4%) | 42 (45.2%) |
| Postmenopausal | 34 (58.6%) | 51 (54.8%) |
| Tumor size (mean ± SD) (range) (cm) | ||
| > 2 | 32 (55.1%) | |
| q 2 | 26 (44.8%) | |
| TNM stage | ||
| I | 25 (43.1%) | |
| II | 33 (56.9%) | |
| Histology subtype | ||
| Ductal | 39 (67.2%) | |
| Lobular | 12 (20.7%) | |
| Other | 7 (12.1%) | |
| Lymph node metastasis | ||
| Yes | 31 (53.4%) | |
| No | 27 (46.4%) | |
| Estrogen receptor (ER) | ||
| Positive | 34 (58.6%) | |
| Negative | 24 (41.4%) | |
| Progesterone receptor (PR) | ||
| Positive | 36 (62.1%) | |
| Negative | 22 (37.9%) | |
| Proliferation index (Ki 67) | ||
| Positive | 30 (51.7%) | |
| Negative | 28 (48.3%) | |
| Her-2 | ||
| Positive | 23 (39.7%) | |
| Negative | 35 (60.3%) |
Data were expressed as N (%).